FGFR3 | ACHONDROPLASIA; ACH | 100800 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
| ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 11-BETA-HYDROXYLASE DEFICIENCY | 202010 | | |
| | | | | |
|
| ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY | 202110 | | |
| | | | | |
|
POLG | ALPERS DIFFUSE DEGENERATION OF CEREBRAL GRAY MATTER WITH HEPATIC
CIRRHOSIS | 203700 | | |
| | | | | |
|
COL4A3 COL4A4 | ALPORT SYNDROME, AUTOSOMAL RECESSIVE | 203780 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
COL4A5 | ALPORT SYNDROME, X-LINKED; ATS | 301050 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
TTR | Amyloidosis, hereditary, transthyretin-related | 105210 | | |
| | | | | |
|
AN2 | ANIRIDIA, TYPE II; AN2 | 106210 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
SLC12A1 | Antenatal Bartter syndrome type 1 | 601678 | | |
| | | | | |
|
KCNJ1 | Antenatal Bartter syndrome type 2 | 241200 | | |
| | | | | |
|
MAGED2 | Antenatal transient Bartter syndrome | 300971 | | |
| | | | | |
|
FGFR2 | ANTLEY-BIXLER SYNDROME; ABS | 207410 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
MYH11 | Aortic aneurysm, familial thoracic 4, AAT4 | 132900 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
ACTA2 | Aortic aneurysm, familial thoracic 6, AAT6 | 611788 | | |
| | | | | |
|
MYLK | AORTIC ANEURYSM, FAMILIAL THORACIC 7 | 613780 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
FGFR2 | APERT SYNDROME | 101200 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGF10 | Aplasia of lacrimal and salivary glands | 602115 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
MRE11A | ATAXIA-TELANGIECTASIA; AT | 208900 | | |
| | | | | |
|
SCNN1A SCNN1B SCNN1G | autosomal recessive Pseudohypoaldosteronism | 264350 | | |
| | | | | |
|
BBS10 | Bardet-Biedl syndrome | 209900 | | |
| | | | | |
|
FGFR2 | Beare-Stevenson cutis gyrata syndrome | 123790 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
COL6A1 COL6A2 COL6A3 | Bethlem Myopathy | 158810 | | |
| | | | | |
|
FLCN | BIRT-HOGG-DUBE SYNDROME | 135150 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
FKBP10 PLOD2 | Bruck syndrome | 609220 | | |
| | | | | |
|
CLCNKB | Classic Bartter syndrome | 607364 | | |
| | | | | |
|
COQ2 | Coenzyme Q10 deficiency, primary, 1 | 607426 | | |
| | | | | |
|
PDSS2 | Coenzyme Q10 deficiency, primary, 3; COQ10D3 | 614652 | | |
| | | | | |
|
COQ6 | Coenzyme Q10 deficiency, primary, 6 | 614650 | | |
| | | | | |
|
LEPRE1 P4HB SEC24D | Cole-Carpenter Syndrome; CLCRP1, CLCRP2 | 112240 | | |
| | | | | |
|
RMND1 | Combined oxidative phosphorylation deficiency 11 | 614922 | | |
| | | | | |
|
NIPBL | CORNELIA DE LANGE SYNDROME; CDLS | 122470 | - MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
CYP11B2 | CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY | 203400 | | |
| | | | | |
|
| CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY | 218030 | | |
| | | | | |
|
SDHB SDHD | COWDEN DISEASE; CD | 158350 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
SEC23A | Craniolenticulosutural dysplasia | 607812 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
ERF | Craniosynostosis 4 | 600775 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
IL11RA | Craniosynostosis and dental anomalies | 614188 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
TWIST1 | Craniosynostosis, type 1 | 123100 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGFR2 FGFR3 | CROUZON SYNDROME | 123500 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
CFTR | CYSTIC FIBROSIS; CF | 219700 | - Multiplex-PCR
- Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
UMOD | cystic kidney disease, autosomal dominant medullary, type 2 | 603860 | | |
| | | | | |
|
CTNS | Cystinosis, nephropathic | 219800 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
SLC3A1 SLC7A9 | CYSTINURIA; CSNU | 220100 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
GJB2 GJB6 | DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 1; DFNB1 | 220290 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
MTRNR1 | Deafness, nonsyndromic sensorineural, mitochondrial | 500008 | | |
| | | | | |
|
CLCN5 | DENT DISEASE | 300009 | | |
| | | | | |
|
AQP2 AVPR2 | DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL DOMINANT | 125800 | | |
| | | | | |
|
AQP2 | DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL RECESSIVE | 222000 | | |
| | | | | |
|
AVPR2 | DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED | 304800 | | |
| | | | | |
|
AVP | DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE | 125700 | | |
| | | | | |
|
HNF1B | DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM | 125853 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
COL3A1 | EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT | 130050 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
COLQ | Endplate acetylcholinesterase deficiency | 603034 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SCN2A | EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11 | 613721 | | |
| | | | | |
|
MYH9 | EPSTEIN SYNDROME | 153650 | | |
| | | | | |
|
MYH9 | Epstein/Fechner syndrome | 153650 | | |
| | | | | |
|
MYH9 | Fechtner syndrome | 153640 | | |
| | | | | |
|
ACTN4 | Focal segmental glomerulosclerosis 1; FSGS1 | 603278 | | |
| | | | | |
|
TRPC6 | Focal segmental glomerulosclerosis 2 | 603965 | | |
| | | | | |
|
CD2AP | Focal segmental glomerulosclerosis 3; FSGS3 | 607832 | | |
| | | | | |
|
CRB2 | Focal segmental glomerulosclerosis 9 | 616220 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
APOL1 | Focal segmental glomerulosclerosis-4 | 612551 | | |
| | | | | |
|
FH | FUMARASE DEFICIENCY | 606812 | | |
| | | | | |
|
OSGEP WDR73 | Galloway-Mowat syndrome | 251300, 617729 | | |
| | | | | |
|
SLC12A3 | GITELMAN SYNDROME | 263800 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
INF2 | Glomerulosclerosis, focal segmental, 5 | 613237 | | |
| | | | | |
|
MYO1E | Hereditary FSGS type 6 | 614131 | | |
| | | | | |
|
CBS | HOMOCYSTINURIA DUE TO CBS DEFICIENCY | 236200 | | |
| | | | | |
|
CYP11B1 CYP11B2 | HYPERALDOSTERONISM, FAMILIAL, TYPE I | 103900 | - Sanger-Sequenzierung
- PCR-Analyse
| |
| | | | | |
|
CLCN2 | Hyperaldosteronism, familial, type II | 605635 | | |
| | | | | |
|
KCNJ5 | Hyperaldosteronism, familial, type II | 613677 | | |
| | | | | |
|
CYP24A1 SLC34A1 | Hypercalcemia, infantile | 143880 | | |
| | | | | |
|
GRHPR | Hyperoxaluria type II | 260000 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
AGXT | Hyperoxaluria, primary, type I | 259900 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
DHDPSL (HOGA1) | Hyperoxaluria, primary, type III | 613616 | | |
| | | | | |
|
CASR | HYPERPARATHYROIDISM, NEONATAL SEVERE PRIMARY; NSHPT | 239200 | | |
| | | | | |
|
REN | Hyperuricemic nephropathy, familial juvenile 2 | 613092 | | |
| | | | | |
|
CASR GNA11 | HYPOCALCEMIA, AUTOSOMAL DOMINANT | 601198 | | |
| | | | | |
|
AP2S1 CASR GNA11 | HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1 (sowie Typ III; HHC3) | 145980, 600740 | | |
| | | | | |
|
FGFR3 | HYPOCHONDROPLASIA; HCH | 146000 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
CLDN19 | Hypomagnesemia with ocular involvement | 248190 | | |
| | | | | |
|
CLDN16 | HYPOMAGNESEMIA, PRIMARY | 248250 | | |
| | | | | |
|
ALPL | HYPOPHOSPHATASIA, ADULT TYPE | 146300 | | |
| | | | | |
|
ALPL | Hypophosphatasia, childhood, infantile | 241510 | | |
| | | | | |
|
HPRT1 | HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1 | 308000 | | |
| | | | | |
|
SMARCAL1 | IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE | 242900 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FAN1 | Interstitial Nephritis | 614817 | | |
| | | | | |
|
FGFR1 | JACKSON-WEISS SYNDROME; JWS | 123150 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
KDM6A KMT2D | Kabuki syndrome | 147920 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGFR1 | Kallmann Syndrome 2 | 147950 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGF10 FGFR2 FGFR3 | Lacrimoauriculodentodigital syndrome | 149730 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
NR3C2 SCNN1B SCNN1G | LIDDLE SYNDROME | 177200 | | |
| | | | | |
|
LIG4 XRCC4 | LIG4 SYNDROME | 606593 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
TGFBR2 | Loesys-Dietz syndrome, type 1B | 610168 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
TGFBR2 | LOEYS-DIETZ SYNDROME, TYPE 2B; LDS2B | 610380 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
KCNJ5 | Long QT syndrome 13; LQT13 | 613485 | | |
| | | | | |
|
FBN1 TGFBR1 TGFBR2 | MARFAN SYNDROME; MFS | 154700 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
HNF1B | Maturity Onset Diabetes of the Young Type V | 137920 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
HNF4A | MATURITY-ONSET DIABETES OF THE YOUNG, TYPE I; MODY1 | 125850 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
CASK | Mental Retardation and Microcephaly with Pontine and Cerebellar Hypoplasia | 300749 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
MMACHC MMADHC | Methylmalonic aciduria and homocystinuria cblC type | 277400 | | |
| | | | | |
|
PCNT RNU4ATAC | MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM Type 1 and 2 | 210710, 210720 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
GPHN MOCS1 MOCS2 | MOLYBDENUM COFACTOR DEFICIENCY | 252150 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGFR3 | MUENKE SYNDROME | 602849 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
| Multiple cutaneous and uterine myomata 1 | 150800 | | |
| | | | | |
|
CDKN1B | MULTIPLE ENDOCRINE NEOPLASIA TYPE IV | 610755 | | |
| | | | | |
|
MEN1 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1 | 131100 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
RET | MULTIPLE ENDOCRINE NEOPLASIA, TYPE II; MEN2A | 171400 | | |
| | | | | |
|
RET | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B | 162300 | | |
| | | | | |
|
DMD | MUSCULAR DYSTROPHY, BECKER TYPE; BMD | 300376 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
- Deletionsscreening
| |
| | | | | |
|
DMD | MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD | 310200 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
LMX1B | NAIL-PATELLA SYNDROME; NPS | 161200 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
ACTA1 TPM2 | Nemaline Myopathy | 161650, 615731 | | |
| | | | | |
|
SLC34A1 | Nephrolithiasis/osteoporosis, hypophosphatemic, 1 | 612286 | | |
| | | | | |
|
NPHP1 | NEPHRONOPHTHISIS 1; NPHP1 | 256100 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
INVS | NEPHRONOPHTHISIS 2; NPHP2 | 602088 | | |
| | | | | |
|
NPHP3 | NEPHRONOPHTHISIS 3; NPHP3 | 604387 | | |
| | | | | |
|
NPHS1 | NEPHROSIS 1, CONGENITAL, FINNISH TYPE; NPHS1 | 256300 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
ARHGDIA | Nephrotic syndrome type 8 | 615244 | | |
| | | | | |
|
WT1 | NEPHROTIC SYNDROME, EARLY-ONSET, WITH DIFFUSE MESANGIAL SCLEROSIS | 256370 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
NPHS2 | Nephrotic syndrome, steroid-resistant, autosomal recessive; SRN1 | 600995 | | |
| | | | | |
|
PLCE1 | NEPHROTIC SYNDROME, TYPE 3; NPHS3 | 610725 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
LAMB2 | Nephrotic syndrome, type 5, with or without ocular abnormalities | 614199 | | |
| | | | | |
|
PTPRO | Nephrotic syndrome, type 6 | 614196 | | |
| | | | | |
|
DGKE | Nephrotic syndrome, type 7 | 615008 | | |
| | | | | |
|
ADCK4 | Nephrotic syndrome, type 9 | 615573 | | |
| | | | | |
|
SMARCA2 | Nicolaides-Braritser Syndrome | 601358 | | |
| | | | | |
|
NBN | NIJMEGEN BREAKAGE SYNDROME | 251260 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
RAD50 | NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD | 613078 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FLCN VHL | Nonpapillary renal cell carcinoma | 144700 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
PTPN11 RIT1 | NOONAN SYNDROME 1; NS1 | 163950 | | |
| | | | | |
|
COL1A1 COL1A2 | Osteogenesis impefecta 2A | 166210 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
COL1A1 COL1A2 | Osteogenesis imperfecta 3 | 259420 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
COL1A1 COL1A2 | Osteogenesis imperfecta 4 | 166220 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
PPIB | Osteogenesis imperfecta 9 | 259440 | | |
| Spezifikation - Pränatale Diagnostik
- Nach Rücksprache
- Molekulargenetisch
| | | | |
|
CRTAP | Osteogenesis imperfecta Typ VII | 610682 | | |
| Spezifikation - Pränatale Diagnostik
- Nach Rücksprache
- Molekulargenetisch
| | | | |
|
LEPRE1 | Osteogenesis imperfecta Typ VIII | 610915 | | |
| Spezifikation - Pränatale Diagnostik
- Nach Rücksprache
- Molekulargenetisch
| | | | |
|
FKBP10 | Osteogenesis imperfecta type VI | 610968 | | |
| Spezifikation - Pränatale Diagnostik
- Nach Rücksprache
- Molekulargenetisch
| | | | |
|
SERPINH1 | Osteogenesis imperfecta type XI | 613849 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SP7 | Osteogenesis imperfecta type XI | 613849 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SERPINF1 | Osteogenesis imperfecta type XII; OI12 | 613982 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
COL1A1 COL1A2 | OSTEOGENESIS IMPERFECTA, TYPE I | 166200 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
IFITM5 | Osteogenesis imperfecta, type V | 610967 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
BMP1 | Osteogenesis imperfecta, type XIII | 614856 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
TMEM38B | Osteogenesis imperfecta, type XIV | 615066 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
WNT1 | Osteogenesis imperfecta, type XV | 615220 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGFR1 | OSTEOGLOPHONIC DYSPLASIA | 166250 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
LRP5 | Osteopetrosis, autosomal dominant Type 1 | 607634 | | |
| | | | | |
|
PLS3 | Osteoporosis | 300910 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
LRP5 | Osteoporosis-pseudoglioma syndrome | 259770 | | |
| | | | | |
|
PRSS1 | PANCREATITIS, HEREDITARY; PCTT | 167800 | | |
| | | | | |
|
PAX2 | PAPILLORENAL SYNDROME | 120330 | | |
| | | | | |
|
SLC26A4 | PENDRED SYNDROME; PDS | 274600 | | |
| | | | | |
|
DIS3L2 | Perlman syndrome | 267000 | | |
| | | | | |
|
FGFR1 FGFR2 | PFEIFFER SYNDROME | 101600 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
LAMB2 | Pierson Syndrome | 609049 | | |
| | | | | |
|
AIP | Pituitary adenoma, growth hormone-secreting | 102200 | | |
| | | | | |
|
DICER1 | Pleuropulmonary blastoma | 601200 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
NPHS2 | PODOCIN; NPHS2 | 604766 | | |
| | | | | |
|
DZIP1L PKHD1 | POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD | 263200 | | |
| | | | | |
|
ALAD | Porphyria, acute hepatic | 612740 | | |
| | | | | |
|
POMC | PROOPIOMELANO-CORTIN DEFICIENCY | 609734 | | |
| | | | | |
|
CUL3 | Pseudohypoaldosteronism, type IIE | 614496 | | |
| | | | | |
|
PAX2 RET | Renal adysplasia | 191830 | | |
| | | | | |
|
MET | RENAL CELL CARCINOMA, PAPILLARY | 605074 | | |
| | | | | |
|
HNF1B | renal cysts and Diabetes syndromes/HNF1beta-associated diseases | 189907 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
BRAT1 | Rigidity and multifocal seizure syndrome, lethal neonatal; RMFSL | 614498 | | |
| | | | | |
|
TWIST1 | SAETHRE-CHOTZEN SYNDROME; SCS | 101400 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
MAGEL2 | Schaaf-Yang syndrome | 615547 | | |
| | | | | |
|
KCNJ10 | Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, and Electrolyte Imbalance Syndrome | 612780 | | |
| | | | | |
|
NHEJ1 | SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION, AND SENSITIVITY TO IONIZING RADIATION | 611291 | | |
| | | | | |
|
IGHMBP2 | SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1; SMARD1 | 604320 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
TRPV4 | Spinal muscular atrophy, distal, congenital nonprogressive; Type VIII (HMN8) | 600175 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
BICD2 | Spinal muscular atrophy, lower extremity-predominant, 2, AD | 615290 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SMN1 SMN2 | SPINAL MUSCULAR ATROPHY, TYPE I; SMA1 | 253300 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
- Mikrosatellitenanalyse
- Deletionsscreening
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SMN1 SMN2 | SPINAL MUSCULAR ATROPHY, TYPE II; SMA2 | 253550 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
- Mikrosatellitenanalyse
- Deletionsscreening
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SMN1 SMN2 | SPINAL MUSCULAR ATROPHY, TYPE III; SMA3 | 253400 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
- Mikrosatellitenanalyse
- Deletionsscreening
| |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
UBA1 | Spinal muscular atrophy, x-linked 2; SMAX2 | 301830 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
SUOX | Sulfite oxidase deficiency | 272300 | | |
| | | | | |
|
FGFR3 | Thanatophoric dysplasia, type II | 187601 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
FGFR3 | THANATOPHORIC DYSPLASIA; TD | 187600 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
ADAMTS13 | THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP | 274150 | | |
| | | | | |
|
RET | THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC | 155240 | | |
| | | | | |
|
FGFR1 | Trigonocephaly | 190440 | | |
| Spezifikation - Pränatale Diagnostik
- Molekulargenetisch
| | | | |
|
TSC2 | TSC2 GENE; TSC2 | 191092 | | |
| | | | | |
|
TSC1 TSC2 | TUBEROUS SCLEROSIS; TS | 191100 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
COL6A1 COL6A2 COL6A3 | Ullrich congenital muscular dystrophy UCMD | 254090 | | |
| | | | | |
|
VHL | VON HIPPEL-LINDAU SYNDROME; VHL | 193300 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
AN2 WT1 | WAGR SYNDROME | 194072 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |
|
BUB1B TRIP13 WT1 | WILMS TUMOR 1; WT1 | 194070 | - Sanger-Sequenzierung
- MLPA (Multiple Ligation-dependent Probe Amplification
| |
| | | | | |